Stock Analysts’ Updated EPS Estimates for July 8th (AA, ARAY, AVAP, AXSM, BTRW, CINF, CLSK, CMC, CMPS, CRNX)

Stock Analysts’ updated eps estimates for Wednesday, July 8th:

Alcoa (NYSE:AA) had its equal weight rating reissued by analysts at Morgan Stanley. They currently have a $53.00 price target on the stock, down from their previous price target of $79.00.

Accuray (NASDAQ:ARAY) had its neutral rating reiterated by analysts at BTIG Research.

Avation (LON:AVAP) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 270 price target on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $290.00 price target on the stock.

Barratt Redrow (LON:BTRW) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a GBX 350 price target on the stock.

Cincinnati Financial (NASDAQ:CINF) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $201.00 target price on the stock, up from their previous target price of $191.00.

Cleanspark (NASDAQ:CLSK) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $19.00 price target on the stock.

Commercial Metals (NYSE:CMC) was upgraded by analysts at BNP Paribas Exane from a neutral rating to an outperform rating. They currently have $75.00 price target on the stock.

Compass Pathways (NASDAQ:CMPS) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $70.00 target price on the stock.

Compass Pathways (NASDAQ:CMPS) was upgraded by analysts at Evercore Inc from an in-line rating to an outperform rating. Evercore Inc currently has $21.00 price target on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its hold rating reaffirmed by analysts at TD Cowen.

CRISPR Therapeutics (NASDAQ:CRSP) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $80.00 price target on the stock.

Community Health Systems (NYSE:CYH) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. The firm currently has $3.00 target price on the stock.

EHang (NASDAQ:EH) had its underperform rating reiterated by analysts at Bank of America Corporation. The firm currently has a $5.40 target price on the stock, down from their previous target price of $13.00.

Figure Technology Solutions (NASDAQ:FIGR) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $55.00 price target on the stock.

The Gym Group (LON:GYM) had its buy rating reissued by analysts at Shore Capital Group Ltd. The firm currently has a GBX 280 price target on the stock.

HCA Healthcare (NYSE:HCA) had its equal weight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $427.00 price target on the stock, down from their previous price target of $496.00.

Leidos (NYSE:LDOS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Lemonade (NYSE:LMND) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $75.00 target price on the stock.

Moelis & Company (NYSE:MC) had its sell rating reissued by analysts at UBS Group AG. UBS Group AG currently has a $60.00 price target on the stock, up from their previous price target of $58.00.

Medpace (NASDAQ:MEDP) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $547.00 price target on the stock, up from their previous price target of $477.00.

Meta Platforms (NASDAQ:META) had its hold rating reiterated by analysts at Needham & Company LLC.

MeiraGTx (NASDAQ:MGTX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $20.00 price target on the stock.

Merck & Co., Inc. (NYSE:MRK) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $142.00 target price on the stock.

Next 15 Group (LON:NFG) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 510 target price on the stock.

Neptune Insurance (NYSE:NP) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $34.00 target price on the stock, up from their previous target price of $32.00.

Ollie’s Bargain Outlet (NASDAQ:OLLI) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $70.00 price target on the stock, down from their previous price target of $152.00.

Occidental Petroleum (NYSE:OXY) was upgraded by analysts at Evercore Inc from an in-line rating to an outperform rating. They currently have $65.00 target price on the stock.

Public Policy (NASDAQ:PPHC) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $18.00 price target on the stock.

Quadrise (LON:QED) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Sabra Healthcare REIT (NASDAQ:SBRA) had its buy rating reaffirmed by analysts at Truist Financial Corporation. They currently have a $22.00 target price on the stock.

Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by analysts at Truist Financial Corporation from a buy rating to a hold rating.

Shawbrook Group (LON:SHAW) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 475 price target on the stock.

System1 Group (LON:SYS1) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 610 price target on the stock.

Truist Financial (NYSE:TFC) had its neutral rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $56.00 target price on the stock, up from their previous target price of $54.00.

The Hanover Insurance Group (NYSE:THG) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $220.00 target price on the stock, up from their previous target price of $211.00.

Titan Mining (NYSEAMERICAN:TII) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $6.50 target price on the stock.

First Tracks Biotherapeutics (NASDAQ:TRAX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $30.00 price target on the stock.

Travelers Companies (NYSE:TRV) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $356.00 price target on the stock, up from their previous price target of $342.00.

Trade Desk (NASDAQ:TTD) was upgraded by analysts at HSBC Holdings plc from a reduce rating to a hold rating. HSBC Holdings plc currently has $20.00 price target on the stock.

Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Raymond James Financial, Inc. from a market perform rating to an outperform rating. They currently have $10.00 target price on the stock.

United Dominion Realty Trust (NYSE:UDR) had its hold rating reiterated by analysts at Truist Financial Corporation. The firm currently has a $41.00 target price on the stock.

Ultrapar Participacoes (NYSE:UGP) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $7.40 price target on the stock, up from their previous price target of $6.80.

Universal Health Services (NYSE:UHS) had its equal weight rating reiterated by analysts at Barclays PLC. The firm currently has a $179.00 target price on the stock.

Ubiquiti (NYSE:UI) had its buy rating reiterated by analysts at BWS Financial. The firm currently has a $980.00 price target on the stock.

Ultimate Products (LON:ULTP) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Unite Group (LON:UTG) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 623 target price on the stock.

Vale (NYSE:VALE) had its equal weight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $16.50 price target on the stock, down from their previous price target of $19.50.

Victoria (LON:VCP) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 60 target price on the stock.

Waters (NYSE:WAT) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $440.00 target price on the stock.